Literature DB >> 6481852

Interaction of polymorphonuclear leukocytes and viruses in humans: adherence of polymorphonuclear leukocytes to respiratory syncytial virus-infected cells.

H Faden, J J Hong, P L Ogra.   

Abstract

The nature of neutrophil-respiratory syncytial virus (RSV) interaction was investigated by assessing factors that influence neutrophil adherence to RSV-infected tissue culture monolayers. The adherence of neutrophils to infected cells was directly proportional to the degree of RSV replication as evidenced by infectious virus production, cytopathological changes, or viral antigen appearance. Sixty-one percent of the neutrophils adhered to the RSV-infected cells as compared with 52.7% on noninfected monolayers (P less than 0.05). The addition of RSV-specific antibody markedly increased polymorphonuclear leukocyte adherence to 88.5% (P less than 0.001). Complement in the absence of antibody augmented polymorphonuclear leukocyte adherence, but to a lesser degree, 69.0% (P less than 0.025). Arachidonic acid metabolism appeared to play a critical role in the adherence process; thromboxane was the single most important arachidonic acid metabolite. Inhibition of thromboxane synthesis reduced antibody-dependent polymorphonuclear leukocyte adherence on RSV-infected cells to 52.3% (P less than 0.025). These observations suggest a role for neutrophils in RSV infection. It is proposed that neutrophils may participate in RSV infection at the site of viral replication through the attachment to infected cells and the subsequent release of mediators of inflammation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6481852      PMCID: PMC254483     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Cellular events in zoster vesicles: relation to clinical course and immune parameters.

Authors:  D A Stevens; R A Ferrington; G W Jordan; T C Merigan
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

2.  Elevated nitroblue tetrazolium dye reduction test response in acute viral respiratory disease.

Authors:  O F Sieber; M L Wilska; R Riggin
Journal:  Pediatrics       Date:  1976-07       Impact factor: 7.124

3.  The leukocyte response during viral respiratory illness in man.

Authors:  R G Douglas; R H Alford; T R Cate; R B Couch
Journal:  Ann Intern Med       Date:  1966-03       Impact factor: 25.391

4.  Value of repeat lumbar puncture in the differential diagnosis of meningitis.

Authors:  R D Feigin; P G Shackelford
Journal:  N Engl J Med       Date:  1973-09-13       Impact factor: 91.245

5.  Virus and interferon effects on cellular prostaglandin biosynthesis.

Authors:  F A Fitzpatrick; D A Stringfellow
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

6.  Comparative adherence of granulocytes to endothelial monolayers and nylon fiber.

Authors:  R R MacGregor; E J Macarak; N A Kefalides
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

7.  Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway.

Authors:  J P Kelly; M C Johnson; C W Parker
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

8.  Adherence of polymorphonuclear leukocytes to nylon: modulation by prostacyclin (PGI2), corticosteroids, and complement activation.

Authors:  J McGillen; R Patterson; J P Phair
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

9.  Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence.

Authors:  A Kaul; R Scott; M Gallagher; M Scott; J Clement; P L Ogra
Journal:  Am J Dis Child       Date:  1978-11

10.  Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness.

Authors:  P J Spagnuolo; J J Ellner; A Hassid; M J Dunn
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

View more
  14 in total

1.  rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.

Authors:  Lan Wu; Tian-gui Huang; Marcia Meseck; Jennifer Altomonte; Oliver Ebert; Katsunori Shinozaki; Adolfo García-Sastre; John Fallon; John Mandeli; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

Review 2.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

Review 3.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 4.  Immunopathological mechanisms in respiratory syncytial virus disease.

Authors:  P J Openshaw
Journal:  Springer Semin Immunopathol       Date:  1995

5.  Effects of paramyxoviral infection on airway epithelial cell Foxj1 expression, ciliogenesis, and mucociliary function.

Authors:  D C Look; M J Walter; M R Williamson; L Pang; Y You; J N Sreshta; J E Johnson; D S Zander; S L Brody
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.

Authors:  A M LeVine; J Gwozdz; J Stark; M Bruno; J Whitsett; T Korfhagen
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 7.  Molecular Basis for Paradoxical Activities of Polymorphonuclear Neutrophils in Inflammation/Anti-Inflammation, Bactericide/Autoimmunity, Pro-Cancer/Anticancer, and Antiviral Infection/SARS-CoV-II-Induced Immunothrombotic Dysregulation.

Authors:  Tsai-Hung Wu; Song-Chou Hsieh; Tsu-Hao Li; Cheng-Hsun Lu; Hsien-Tzung Liao; Chieh-Yu Shen; Ko-Jen Li; Cheng-Han Wu; Yu-Min Kuo; Chang-Youh Tsai; Chia-Li Yu
Journal:  Biomedicines       Date:  2022-03-25

8.  Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes.

Authors:  R Arnold; F Werner; B Humbert; H Werchau; W König
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

9.  Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea.

Authors:  T M Tumpey; S H Chen; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.

Authors:  R Arnold; B Humbert; H Werchau; H Gallati; W König
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.